Literature DB >> 34519901

A negative association between low-density lipoprotein cholesterol level and infection risk in elderly stage 5 chronic kidney disease patients.

Ping Liu1, Shuying Zhang2, Lijuan Jiang3, Jinhong Ma2, Xiaonan Shao4.   

Abstract

BACKGROUND: To explore the relationship between low-density lipoprotein cholesterol (LDL-C) level and infection risk in elderly stage 5 kidney disease (CKD) patients.
METHODS: This study retrospectively analyzed all 378 patients with grade 5 CKD over 60 years old treated in the Nephrology Department of our hospital from February 2014 to July 2019, including 286 cases with infection and 92 cases without. According to LDL-C levels, the patients were divided into three groups (Tertile 1-Tertile 3). Basic patient data and laboratory test results were collected for all three groups for analysis.
RESULTS: The incidence of infection showed a gradually decreasing trend in the three groups (from 80.2, 78.6 to 68.3%), along with increasing LDL-C levels from Tertile 1 to Tertile 3, although the differences were not statistically significant (p = 0.075). After fully adjusting for confounding factors, the risk of infection was significantly reduced (OR = 0.646, 95% CI 0.420-0.993, p = 0.046) with increasing LDL-C levels. For the LDL-C levels of the three groups, the rising trend of LDL-C was significantly associated with the reduction in infection risk (OR = 0.545, 95% CI 0.317-0.937, p = 0.028). Curve fitting revealed that LDL-C levels were linearly negatively associated with the risk of infection, and the relationship between the two was not affected by the other factors (p for interaction: 0.567-1.000).
CONCLUSIONS: LDL-C level is linearly negatively associated with the risk of infection in elderly patients with stage 5 CKD.
© 2021. Japanese Society of Nephrology.

Entities:  

Keywords:  Aged; Chronic kidney disease; Infections; Lipoproteins

Mesh:

Substances:

Year:  2021        PMID: 34519901     DOI: 10.1007/s10157-021-02134-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  27 in total

1.  Innate and acquired immunity intersect in a global view of the acute-phase response.

Authors:  Joo-Yeon Yoo; Stephen Desiderio
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-22       Impact factor: 11.205

Review 2.  Inflammation in end-stage renal disease--what have we learned in 10 years?

Authors:  Juan J Carrero; Peter Stenvinkel
Journal:  Semin Dial       Date:  2010 Sep-Oct       Impact factor: 3.455

3.  Biomarkers and risk factors for sepsis in stage 5 chronic kidney disease: a retrospective case-control study.

Authors:  Lijuan Jiang; Xiaonan Shao; Wei Xing; Yanbei Sun
Journal:  Int Urol Nephrol       Date:  2019-02-25       Impact factor: 2.370

Review 4.  Causes, consequences, and reversal of immune system aging.

Authors:  Encarnacion Montecino-Rodriguez; Beata Berent-Maoz; Kenneth Dorshkind
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

Review 5.  Effect of uremia on structure and function of immune system.

Authors:  Nosratola D Vaziri; Madeleine V Pahl; Albert Crum; Keith Norris
Journal:  J Ren Nutr       Date:  2012-01       Impact factor: 3.655

Review 6.  Immune Dysfunction and Risk of Infection in Chronic Kidney Disease.

Authors:  Maaz Syed-Ahmed; Mohanram Narayanan
Journal:  Adv Chronic Kidney Dis       Date:  2019-01       Impact factor: 3.620

Review 7.  Chronic kidney disease and the ageing population.

Authors:  Marcello Tonelli; Miguel Riella
Journal:  Nephron Clin Pract       Date:  2014-12-09

8.  PC6 acupoint stimulation for the prevention of postcardiac surgery nausea and vomiting: a protocol for a two-group, parallel, superiority randomised clinical trial.

Authors:  Marie Cooke; Claire Rickard; Ivan Rapchuk; Kiran Shekar; Andrea P Marshall; Tracy Comans; Suhail Doi; John McDonald; Amy Spooner
Journal:  BMJ Open       Date:  2014-11-13       Impact factor: 2.692

Review 9.  Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.

Authors:  Nathan R Hill; Samuel T Fatoba; Jason L Oke; Jennifer A Hirst; Christopher A O'Callaghan; Daniel S Lasserson; F D Richard Hobbs
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

10.  End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal Transplantation.

Authors:  Clémence Carron; Jean-Paul Pais de Barros; Emilie Gaiffe; Valérie Deckert; Hanane Adda-Rezig; Caroline Roubiou; Caroline Laheurte; David Masson; Dominique Simula-Faivre; Pascale Louvat; Bruno Moulin; Luc Frimat; Philippe Rieu; Christiane Mousson; Antoine Durrbach; Anne-Elisabeth Heng; Philippe Saas; Didier Ducloux; Laurent Lagrost; Jamal Bamoulid
Journal:  Front Immunol       Date:  2019-08-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.